Tuberc Respir Dis > Volume 65(2); 2008 > Article
Tuberculosis and Respiratory Diseases 2008;65(2):125-130.
DOI: https://doi.org/10.4046/trd.2008.65.2.125    Published online August 1, 2008.
Two Cases of Endobronchial Actinomycosis that were Cured by Operation and Short Term Antibiotics Therapy.
Yong Kwan Lee, Ho Sung Lee, Mee Hye Oh, Jae Sung Choi, Ki Hyun Seo, Yong Hoon Kim, Ju Ock Na, Hun Gyu Hwang
1Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea. juokna@hanmail.net
2Department of Pathology, Soonchunhyang University College of Medicine, Cheonan, Korea.
Abstract
Endobronchial actinomycosis is a rare chronic suppurative granulomatous infection of the bronchus, and this is sometimes related with a foreign body or a broncholith. The traditional treatment of endobroncial actinomycosis is intravenous antibiotics for 2 to 6 weeks and then oral antibiotics therapy for 6 to 12 months. We report here on 2 cases of endobronchial actinomycosis that were associated with a broncholith and a foreign body, respectively. Surgery followed by short term antibiotics therapy for only 20 days and 34 days, respectively, was effective as treatment for the endobronchial actinomycosis in our cases. After treatment, there were no complications or recurrence during the following period. We suggest that short term antibiotics therapy combined with a surgical operation might be effective as treatment for primary endobronchial actinomycosis, and especially when this illness is combined with a foreign body or a broncholith, as compared with traditional long term antibiotic therapy.
Key Words: Endobronchial actinomycosis, Treatment, Short term antibiotics


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2024 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next